| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $1.1 (Beat by $0.06) |
| EPS GAAP Actual | $1.1 (Beat by $0.06) |
| Revenue Actual | $1.1695B |
| Revenue Surprise | Beat by $1169.5M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.16409 |
| EPS GAAP Estimate | $1.16409 |
| Revenue Estimate | $1.101047366B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 8.10464 | 9.94 | 7.84737 | 8.41473 | 4 |
| Dec 2027 | 6.41252 | 12.56 | 6.30239 | 6.7036 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.5 | -0.67784 | 1.1695B | 7.23% | 63.95M |
| FQ2 2025 (Jun 2025) | 0.56 | 0.56 | 1.1398B | 8.69% | 1139.8M |
| FQ1 2025 (Mar 2025) | 1.2 | 1.2 | 1.0957B | 6.8% | 1095.7M |
| FQ4 2024 (Dec 2024) | 0.34 | 0.34 | 1.0368B | 7.96% | 1036.8M |
| FQ3 2024 (Sep 2024) | -0.77 | -0.77 | 1.085B | 10.72% | 1085M |
| FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 1.0408B | 6.99% | 1040.8M |
| FQ1 2024 (Mar 2024) | 0.49 | 0.49 | 1.0212B | 7.92% | 1021.2M |
| FQ4 2023 (Dec 2023) | -0.11 | -0.11 | 0.9543B | 100% | 954.3M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.16409
Consensus Revenue Estimates
1.101047366B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.37938 | -- | 1.34348 | 1.40481 | 7 |
| FQ3 2027 (Sep 2027) | 1.41903 | -- | 1.39521 | 1.46397 | 5 |
| FQ2 2027 (Jun 2027) | 1.4097 | -- | 1.38603 | 1.45434 | 5 |
| FQ1 2027 (Mar 2027) | 1.37048 | -- | 1.34747 | 1.41388 | 5 |
| FQ4 2026 (Oct 2026) | 1.37148 | -- | 1.33705 | 1.38944 | 6 |
| FQ3 2026 (Jul 2026) | 1.20621 | 58.55 | 1.17593 | 1.222 | 11 |
| FQ2 2026 (Jun 2026) | 1.20263 | 53.44 | 1.18387 | 1.23339 | 9 |
| FQ1 2026 (Mar 2026) | 1.07458 | -11.67 | 1.05782 | 1.10206 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.3B | -- | 1.27B | 1.31B | 14 |
| FQ3 2027 (Sep 2027) | 1.28B | -- | 1.26B | 1.31B | 6 |
| FQ2 2027 (Jun 2027) | 1.28B | -- | 1.26B | 1.31B | 6 |
| FQ1 2027 (Mar 2027) | 1.25B | -- | 1.24B | 1.28B | 6 |
| FQ4 2026 (Oct 2026) | 1.16B | -- | 1.14B | 1.17B | 6 |
| FQ3 2026 (Jul 2026) | 1.13B | -3.85 | 1.1B | 1.14B | 6 |
| FQ2 2026 (Jun 2026) | 1.13B | -1.26 | 1.11B | 1.15B | 12 |
| FQ1 2026 (Mar 2026) | 1.1B | 0.04 | 1.08B | 1.12B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.17784 | 0.5 | -0.67784 | -135.57% |
| FQ2 2025 (Jun 2025) | 0.56 | 0.56 | 100% | |
| FQ1 2025 (Mar 2025) | 1.2 | 1.2 | 100% | |
| FQ4 2024 (Dec 2024) | 0.34 | 0.34 | 100% | |
| FQ3 2024 (Sep 2024) | -0.77 | -0.77 | 100% | |
| FQ2 2024 (Jun 2024) | 0.44 | 0.44 | 100% | |
| FQ1 2024 (Mar 2024) | 0.49 | 0.49 | 100% | |
| FQ4 2023 (Dec 2023) | -0.11 | -0.11 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.11B | $1.17B | $63.95M | 5.47% |
| FQ2 2025 (Jun 2025) | $0B | $1.14B | $1139.8M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.1B | $1095.7M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.04B | $1036.8M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.09B | $1085M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.04B | $1040.8M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.02B | $1021.2M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.95B | $954.3M | 100% |